(Return tabled) Question No. 1123 Ms. Kirsty Duncan: With respect to the government’s position on chronic cerebrospinal venous insufficiency (CCSVI): (a) does the government track clinical trials on CCSVI currently being undertaken by other countries and, if yes, what are all clinical trials, identified by phase, currently being undertaken worldwide, (i) which countries are undertaking Phase lll trials; (b) does the government question whether CCSVI exists and, if yes, (i) why does the government not question whether treating CCSVI actually improves quality of life for Canadians with multiple sclerosis (MS); (c) how many cases of " major complications associated with venous angioplasty" have occurred in Canada and, if it is not possible ...[+++]to give this number, why, (i) what are identified complications to CCSVI and, for each complication, how many cases versus the number of procedures undertaken have occurred; (d) what are all procedures that have been performed on veins in Canada, including, procedures for Budd-Chiari syndrome and May-Thurner syndrome; (e) what is the government's position on ballooning veins and why does it consider that ballooning veins even once could be unsafe on fragile veins, even though participants involved in the proposed clinical trial will experience two procedures-one real, one simulated-in a one-year period; (f) is the government consulting with Canadians with MS, if so, (i) provide a list of all CCSVI groups the Minister of Health has met with along with the dates of the meetings, (ii) provide a list of all MS groups the Minister of Health has met with along with the dates of the meetings, (iii) provide the number of Canadians with MS the Minister of Health has met and the dates of all meetings, and if the government is not consulting, (iv) why not; (g) how does inviting the investigators of the seven MS-funded CCSVI studies to participate in the consensus workshop on ultrasound imaging meet CIHR's conflict of interest g ...

9B117 Test benches and test stands for solid or liquid propellant rockets or rocket motors, having either of the following characteristics:

4.2.1. The brake forces (T) for each subject brake (for the same control line pressure pm) necessary to produce the drag force specified for both Type I and Type III test conditions shall not exceed the values Te as stated in the Record of Test Results, Appendix 2, point 2 of this Annex, which were taken as a basis for the test of the reference brake.

A vehicle which is representative of the type(s) for which the replacement brake lining assembly approval is required shall be equipped with the replacement brake lining assemblies of the type for which approval is requested and instrumented for brake testing as required by the Directive.

The Commission has approved an operation by which the Robert Bosch GmbH intends to acquire the total worldwide "hydraulic brakes" business including anti-lock systems (ABS) for hydraulic brakes from Allied Signal Inc. Bosch is a German group of companies, mainly being active in the development, manufacture and sale of products in the fields of automotive equipment, power tools, heating systems communication technology and manufactured products.

Sadly, clinical trials, or the lack of Canadian participation in clinical trials, can also be the millstone that delays or even denies Canadian patients access to new therapies.